多参数CT用于识别高危非酒精性脂肪性肝病的效用
本研究纳入186例经活检证实的非酒精性脂肪性肝病患者,评估实验室指标与CT参数识别高危非酒精性脂肪性肝病(进展期纤维化F3及以上)的价值。结果显示FIB-4评分与主观读片评估对高危非酒精性脂肪性肝病识别效能最佳,联合应用AUC达0.82;而CT对非酒精性脂肪性肝炎的识别效能有限,各CT特征AUC均低于0.60。
要点
- FIB-4评分识别高危非酒精性脂肪性肝病的ROC AUC为0.75。
- 主观读片评估识别高危非酒精性脂肪性肝病的AUC读片者1为0.78、读片者2为0.79。
- FIB-4与主观评分互补,联合识别高危非酒精性脂肪性肝病的AUC为0.82。
关键影像表现/征象
- 高危非酒精性脂肪性肝病定义为非酒精性脂肪性肝病合并进展期纤维化(F3期或更高)。
- 非酒精性脂肪性肝炎定义为存在任何小叶内炎症和肝细胞气球样变。
- CT指标包括肝脏衰减、肝段体积比、脾脏体积、肝表面结节评分及部分纹理特征。
- 两位读片者主观评估非酒精性脂肪性肝炎(存在或不存在)和纤维化(F0-F4期)。
诊断标准与关键数值
- FIB-4评分与纤维化相关,识别高危非酒精性脂肪性肝病的ROC AUC为0.75。
- 单一CT参数中肝段体积比和脾脏体积表现最佳,识别高危非酒精性脂肪性肝病的AUC均为0.69。
- 主观读片评估在所有参数中表现最佳,识别高危非酒精性脂肪性肝病的AUC读片者1为0.78、读片者2为0.79。
- FIB-4与主观评分互补,联合识别高危非酒精性脂肪性肝病的AUC为0.82。
- 评估非酒精性脂肪性肝炎时FIB-4表现最佳(AUC为0.68),所有单一CT特征和主观评估的AUC均低于0.60。
临床应用与阅片要点
- FIB-4评分与多项CT表现可识别高危非酒精性脂肪性肝病(进展期纤维化或肝硬化)。
- CT上非酒精性脂肪性肝炎的存在难以识别。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The purpose of this study was to evaluate the utility of laboratory and CT metrics in identifying patients with high-risk nonalcoholic fatty liver disease (NAFLD). MATERIALS AND METHODS. Patients with biopsy-proven NAFLD who underwent CT within 1 year of biopsy were included. Histopathologic review was performed by an experienced gastrointestinal pathologist to determine steatosis, inflammation, and fibrosis. The presence of any lobular inflammation and hepatocyte ballooning was categorized as nonalcoholic steatohepatitis (NASH). Patients with NAFLD and advanced fibrosis (stage F3 or higher) were categorized as having high-risk NAFLD. Aspartate transaminase to platelet ratio index and Fibrosis-4 (FIB-4) laboratory scores were calculated. CT metrics included hepatic attenuation, liver segmental volume ratio (LSVR), splenic volume, liver surface nodularity score, and selected texture features. In addition, two readers subjectively assessed the presence of NASH (present or not present) and fibrosis (stages F0-F4). RESULTS. A total of 186 patients with NAFLD (mean age, 49 years; 74 men and 112 women) were included. Of these, 87 (47%) had NASH and 112 (60%) had moderate to severe steatosis. A total of 51 patients were classified as fibrosis stage F0, 42 as F1, 23 as F2, 37 as F3, and 33 as F4. Additionally, 70 (38%) had advanced fibrosis (stage F3 or F4) and were considered to have high-risk NAFLD. FIB-4 score correlated with fibrosis (ROC AUC of 0.75 for identifying high-risk NAFLD). Of the individual CT parameters, LSVR and splenic volume performed best (AUC of 0.69 for both for detecting high-risk NAFLD). Subjective reader assessment performed best among all parameters (AUCs of 0.78 for reader 1 and 0.79 for reader 2 for detecting high-risk NAFLD). FIB-4 and subjective scores were complementary (combined AUC of 0.82 for detecting high-risk NAFLD). For NASH assessment, FIB-4 performed best (AUC of 0.68), whereas the AUCs were less than 0.60 for all individual CT features and subjective assessments. CONCLUSION. FIB-4 and multiple CT findings can identify patients with high-risk NAFLD (advanced fibrosis or cirrhosis). However, the presence of NASH is elusive on CT.
引用
- Lubner MG, Graffy PM, Said A, et al. Utility of Multiparametric CT for Identification of High-Risk NAFLD. AJR Am J Roentgenol. 2021. PMID: 33474981. doi:10.2214/AJR.20.22842
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。